Rheumatology Academy

Where education meets excellence.
The latest rheumatology CME
& clinical updates you need.

Where education meets excellence.
The latest rheumatology CME & clinical updates you need.

Can We Prevent Psoriatic Arthritis Before Diagnosis?
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Living Rheum
Can We Prevent Psoriatic Arthritis Before Diagnosis?
- Laura Coates, MBChB, MRCP, PhD
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living Rheum
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
- Laura Coates, MBChB, MRCP, PhD
Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Molecular Signals and Early Detection in Psoriatic Arthritis
Molecular Signals and Early Detection in Psoriatic Arthritis
Living Rheum
Molecular Signals and Early Detection in Psoriatic Arthritis
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living Rheum
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
- Gary S. Firestein, MD
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
Living Rheum
Exploring Cadherin-6: A Key Driver of Inflammation in Rheumatoid Arthritis
- Gary S. Firestein, MD
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
DermConsult
TYK2 Inhibition with Zasocitinib Delivers Early Benefit Across PsA Domains
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living Rheum
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings